Latest Shareholder Approvals News

Liberty Metals has secured an option to acquire three strategically located critical mineral projects in Brazil, targeting high-purity rutile and rare earth elements. This move positions the company in a Tier 1 mining jurisdiction with promising exploration upside.

American West Metals has raised A$7 million at a premium to advance its West Desert Project, home to the largest and highest-grade indium resource in the US. The funding includes a strategic $2 million investment from Tribeca Investment Partners and aims to accelerate critical metals development amid supportive US policies.

Auris Minerals has raised $3.2 million through a strategic placement to expand its geological team and fast-track exploration in the Bryah Basin, focusing on copper, gold, and rare earths.

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

QuickFee Limited reported a 9% revenue increase in Q1 FY26, driven by strong Australian Finance growth despite a US Finance dip. The company completed a US Pay Now business sale for US$26.35 million and announced a 7.5 cents per share capital return, alongside a CEO appointment.

Mount Gibson Iron Limited has agreed to acquire a 50% interest in the Central Tanami Gold Project, marking a strategic shift towards gold production while maintaining steady iron ore operations at Koolan Island.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Aurumin Limited has sent out its Scheme Booklet detailing the proposed acquisition by Brightstar Resources, setting the stage for shareholder meetings in November. Securityholders are urged to review the materials carefully before voting.

Finbar Group Limited’s 2025 AGM confirmed strong shareholder support for key resolutions as the company reported record sales and unveiled a robust $1.2 billion development pipeline focused on mid-market apartments in Perth.

Biotron Limited is set to acquire Sedarex Limited, gaining global patents for SedRx, a next-generation general anaesthetic, supported by a $2.5 million capital raising to fund regulatory and development milestones.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.

Saunders International has completed its acquisition of Aqua Metro, a key player in Victoria's water infrastructure sector, marking a strategic expansion into multidisciplinary water projects.